BioAge Labs, Inc. (BIOA)
9.65
-0.43
(-4.27%)
USD |
NASDAQ |
Aug 28, 16:00
9.65
0.00 (0.00%)
Pre-Market: 20:00
BioAge Labs Net Income (Quarterly) : -26.10M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.10M |
| March 31, 2026 | -22.25M |
| December 31, 2025 | -25.94M |
| September 30, 2025 | -20.17M |
| June 30, 2025 | -21.56M |
| March 31, 2025 | -12.93M |
| December 31, 2024 | -21.13M |
| Date | Value |
|---|---|
| September 30, 2024 | -23.41M |
| June 30, 2024 | -13.58M |
| March 31, 2024 | -12.99M |
| December 31, 2023 | -20.96M |
| September 30, 2023 | -14.62M |
| June 30, 2023 | -17.19M |
| March 31, 2023 | -11.08M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.095B |
| Pfizer Inc. | -246.00M |
| Oramed Pharmaceuticals, Inc. | 78.16M |
| Liquidia Corp. | 74.72M |
| Neumora Therapeutics, Inc. | -43.08M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.451M |
| Total Expenses (Quarterly) | 28.55M |
| EPS Diluted (Quarterly) | -0.582 |
| Enterprise Value | 125.84M |
| Gross Profit Margin (Quarterly) | 97.14% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -24.73% |
| Normalized Earnings Yield | -24.63 |